Imipramine for the treatment of fibrositis: a therapeutic trial.
Open Access
- 1 November 1985
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 44 (11) , 752-753
- https://doi.org/10.1136/ard.44.11.752
Abstract
Twenty fibrositic patients were treated with imipramine 50-75 mg/day. Only two patients responded favourably. Nineteen patients stopped therapy during the initial three-month period: 14 of them due to lack of response, while two of these concomitantly disclosed side effects. The additional five patients stopped therapy mainly due to side effects, while only one of them improved with therapy. One patient, only, improved and adhered to therapy for more than three months.This publication has 7 references indexed in Scilit:
- Clinical characteristics of fibrositisArthritis & Rheumatism, 1983
- Fibrositis and psychologic disturbanceArthritis & Rheumatism, 1982
- Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controlsSeminars in Arthritis and Rheumatism, 1981
- ‘Fibrositis’ as a Disorder of Pain ModulationClinics in Rheumatic Diseases, 1979
- Diagnosis and Management of Fibrositis Syndrome and Psychogenic RheumatismMedical Clinics of North America, 1979
- Induction of Neurasthenic Musculoskeletal Pain Syndrome by Selective Sleep Stage DeprivationPsychosomatic Medicine, 1976
- Musculosketal Symptoms and Non-REM Sleep Disturbance in Patients with “Fibrositis Syndrome” and Healthy SubjectsPsychosomatic Medicine, 1975